Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZE: Tenapanor for Hyperphosphatemia in CKD
NCT04549597Phase 4Completed
- Sponsor
- Ardelyx
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenapanor in hyperphosphatemia, sponsored by Ardelyx. Started Nov 2020; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT04549597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04549597.